3-(3-Ethylphenyl)propan-1-amine | 142332-83-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-(3-Ethylphenyl)propan-1-amine
• CAS: 142332-83-0
• 化学式: C₁₁H₁₇N
• 分子量: 163.26
• InChiKey: VLAMZPHIBRTAAL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• Antimicrobial Compounds and Methods of Making and Using the Same
  申请人：Duffy Erin M.

  公开号：US20120220566A1

  公开（公告）日：2012-08-30

  The present invention relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for treating, preventing, and reducing the risk of microbial infections in humans and animals.

  本发明涉及抗微生物化合物领域，以及其制备和使用方法。这些化合物可用于治疗、预防和降低人类和动物微生物感染的风险。
• Styrenyl derivative compounds for treating ophthalmic diseases and disorders
  申请人：Acucela Inc.

  公开号：US10201545B2

  公开（公告）日：2019-02-12

  The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative compounds, and compositions comprising these compounds, that are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.

  本发明一般涉及治疗神经退行性疾病和失调，特别是眼科疾病和失调的组合物和方法。本发明提供了苯乙烯基衍生物化合物，包括但不限于二苯乙烯基衍生物化合物，以及包含这些化合物的组合物，可用于治疗和预防眼科疾病和失调，包括老年性黄斑变性（AMD）和Stargardt病。
• SULFUR-LINKED COMPOUNDS FOR TREATING OPTHALMIC DISEASES AND DISORDERS
  申请人：Acucela, Inc.

  公开号：EP2344451A2

  公开（公告）日：2011-07-20
• US9193731B2
  申请人：——

  公开号：US9193731B2

  公开（公告）日：2015-11-24
• [EN] SULFUR-LINKED COMPOUNDS FOR TREATING OPTHALMIC DISEASES AND DISORDERS<br/>[FR] COMPOSANTS À LIAISON SOUFRE POUR LE TRAITEMENT DE MALADIES ET DE TROUBLES OPHTALMIQUES
  申请人：ACUCELA INC

  公开号：WO2010028088A2

  公开（公告）日：2010-03-11

  Provided are sulphur-linked compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.